Thermo Fisher Scientific Inc (NYSE:TMO) SVP Gregory J. Herrema sold 30,000 shares of the stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $176.02, for a total value of $5,280,600.00. Following the completion of the transaction, the senior vice president now owns 67,016 shares in the company, valued at approximately $11,796,156.32. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Thermo Fisher Scientific Inc (NYSE TMO) opened at 188.30 on Friday. The company has a market cap of $73.46 billion, a price-to-earnings ratio of 32.80 and a beta of 1.05. The stock has a 50 day moving average price of $181.07 and a 200-day moving average price of $171.15. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $194.30.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.03. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.92 billion. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The firm’s quarterly revenue was up 10.2% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.03 EPS. On average, analysts predict that Thermo Fisher Scientific Inc will post $9.35 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Investors of record on Friday, September 15th will be paid a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 annualized dividend and a dividend yield of 0.32%. Thermo Fisher Scientific’s payout ratio is currently 10.45%.

ILLEGAL ACTIVITY NOTICE: This article was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another domain, it was illegally stolen and reposted in violation of international copyright laws. The original version of this article can be accessed at https://www.dailypolitical.com/2017/09/24/gregory-j-herrema-sells-30000-shares-of-thermo-fisher-scientific-inc-tmo-stock.html.

TMO has been the topic of several recent research reports. Deutsche Bank AG set a $200.00 price target on Thermo Fisher Scientific and gave the stock a “buy” rating in a report on Saturday, June 10th. BidaskClub lowered Thermo Fisher Scientific from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 27th. Citigroup Inc. reiterated a “buy” rating and issued a $201.00 price target (up previously from $182.00) on shares of Thermo Fisher Scientific in a report on Monday, July 10th. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $199.00 price target on the stock in a report on Tuesday, July 11th. Finally, Wells Fargo & Company reiterated an “outperform” rating and issued a $200.00 price target (up previously from $195.00) on shares of Thermo Fisher Scientific in a report on Thursday, July 13th. One investment analyst has rated the stock with a hold rating, sixteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $194.33.

Several institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in shares of Thermo Fisher Scientific by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 26,600,394 shares of the medical research company’s stock worth $4,640,970,000 after buying an additional 629,093 shares during the last quarter. BlackRock Inc. grew its stake in shares of Thermo Fisher Scientific by 1.6% in the 2nd quarter. BlackRock Inc. now owns 23,355,469 shares of the medical research company’s stock worth $4,074,828,000 after buying an additional 366,584 shares during the last quarter. Capital Research Global Investors grew its stake in shares of Thermo Fisher Scientific by 29.8% in the 2nd quarter. Capital Research Global Investors now owns 17,304,897 shares of the medical research company’s stock worth $3,019,185,000 after buying an additional 3,973,136 shares during the last quarter. State Street Corp grew its stake in shares of Thermo Fisher Scientific by 1.0% in the 1st quarter. State Street Corp now owns 16,085,954 shares of the medical research company’s stock worth $2,470,802,000 after buying an additional 164,367 shares during the last quarter. Finally, Capital World Investors grew its stake in shares of Thermo Fisher Scientific by 6.1% in the 2nd quarter. Capital World Investors now owns 11,759,734 shares of the medical research company’s stock worth $2,051,721,000 after buying an additional 671,637 shares during the last quarter. Institutional investors own 83.36% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.